Cleared Special

K182992 - BGM014 Blood Glucose Monitoring System

K182992 is the FDA 510(k) clearance for BGM014 Blood Glucose Monitoring System by Apex BioTechnology Corp.. It is a Class 2 Chemistry device (product code NBW) cleared through the Special 510(k) pathway after a 30-day FDA review.

K182992 · Apex BioTechnology Corp. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
30d
Days
Class 2
Risk

K182992 is an FDA 510(k) clearance for the BGM014 Blood Glucose Monitoring System. Classified as System, Test, Blood Glucose, Over The Counter (product code NBW), Class II - Special Controls.

Submitted by Apex BioTechnology Corp. (Hsinchu, TW). The FDA issued a Cleared decision on November 28, 2018 after a review of 30 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1345 - the FDA in vitro diagnostics and chemistry framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Apex BioTechnology Corp. devices

Submission Details

510(k) Number K182992 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 29, 2018
Decision Date November 28, 2018
Days to Decision 30 days
Submission Type Special
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
58d faster than avg
Panel avg: 88d · This submission: 30d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code NBW System, Test, Blood Glucose, Over The Counter
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1345
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - NBW System, Test, Blood Glucose, Over The Counter

All 235
Devices cleared under the same product code (NBW) and FDA review panel - the closest regulatory comparables to K182992.
POPS! one Blood Glucose Monitoring System
K181588 · Taidoc Technology Corporation · Nov 2018
Tyson Bio HS100 Blood Glucose Monitoring System, Tyson Bio HS100-B Blood Glucose Monitoring System
K182046 · Tyson Bioresearch, Inc. · Nov 2018
Tyson Bio HT100-A Blood Glucose Monitoring System
K182047 · Tyson Bioresearch, Inc. · Nov 2018
GLUCOCARD Shine Connex Blood Glucose Monitoring System, GLUCOCARD Shine Express Blood Glucose Monitoring System
K181273 · I-Sens, Inc. · Nov 2018
On Call Sure Blood Glucose Monitoring System, On Call Sure Sync Blood Glucose Monitoring System
K181527 · ACON Laboratories, Inc. · Oct 2018
Oh'Care Lite Smart Blood Glucose Monitoring System
K182286 · Osang Healthcare Co. , Ltd. · Sep 2018